Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Chengsen, Xue"'
Autor:
Jeffrey E. Segall, John Condeelis, Erik Sahai, Zhong-Yin Zhang, Kun-Lin Tsai, Stefania Violini, Mazen Sidani, Fubo Liang, Jeffrey Wyckoff, Chengsen Xue
Supplementary Movie from Epidermal Growth Factor Receptor Overexpression Results in Increased Tumor Cell Motility In vivo Coordinately with Enhanced Intravasation and Metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bbedf3e6c92a97c92f9e52bd0ee161c
https://doi.org/10.1158/0008-5472.22364660
https://doi.org/10.1158/0008-5472.22364660
Autor:
Jeffrey E. Segall, John Condeelis, Erik Sahai, Zhong-Yin Zhang, Kun-Lin Tsai, Stefania Violini, Mazen Sidani, Fubo Liang, Jeffrey Wyckoff, Chengsen Xue
Although overexpression of the epidermal growth factor receptor (EGFR; ErbB1) has been correlated with poor prognosis in breast and other cancers, clinical trials of ErbB1 inhibitors have shown limited efficacy in inhibiting tumor proliferation. To e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2797cb4b31020280f7853c53ee28f855
https://doi.org/10.1158/0008-5472.c.6494309.v1
https://doi.org/10.1158/0008-5472.c.6494309.v1
Autor:
Jeffrey E. Segall, Zhong-Yin Zhang, Joseph Locker, Mimi Kim, Kun-Lin Tsai, Hong Qian, Jeffrey Wyckoff, Magalis Vuolo, Radma Mahmood, Fubo Liang, Chengsen Xue
Supplementary Table 1 from ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd9b0022bbb9a783434e64f9c0782f9
https://doi.org/10.1158/0008-5472.22366547.v1
https://doi.org/10.1158/0008-5472.22366547.v1
Autor:
Jeffrey E. Segall, Zhong-Yin Zhang, Joseph Locker, Mimi Kim, Kun-Lin Tsai, Hong Qian, Jeffrey Wyckoff, Magalis Vuolo, Radma Mahmood, Fubo Liang, Chengsen Xue
A better understanding of how epidermal growth factor receptor family members (ErbBs) contribute to metastasis is important for evaluating ErbB-directed therapies. Activation of ErbB3/ErbB2 heterodimers can affect both proliferation and motility. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c022e43da2970de51e849824703ae1
https://doi.org/10.1158/0008-5472.c.6495188
https://doi.org/10.1158/0008-5472.c.6495188
Autor:
Chengsen Xue, Timothy K. Amukele
Publikováno v:
Cancer Research. 82:1958-1958
Circulating Tumor Cells (CTC) are a prognostic biomarker for some types of malignant epithelial cancers and have been correlated with poor clinical outcomes. However, the routine measurement of CTC in clinical practice is still very uncommon and some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0686093be42319d6c4f8c287cc146ad9
https://doi.org/10.1158/1538-7445.am2022-1958
https://doi.org/10.1158/1538-7445.am2022-1958
Autor:
Weiguo Zhong, Christina D. Swenson, Joanne Cuomo, Yeji Cho, Thomas W. Mc Closkey, Chengsen Xue
Publikováno v:
Cancer Research. 81:512-512
The success of inhibiting PD1 on T cells for cancer immunotherapy initiated strong interest in studying therapeutic antibodies to alter the adaptive immune system. As the knowledge of neoantigens, oncogenes, and autoantigens is rapidly accelerating,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1925477f977a3b59d778c2377a0faaa
https://doi.org/10.1158/1538-7445.am2021-512
https://doi.org/10.1158/1538-7445.am2021-512
Autor:
Joanne Cuomo, Chengsen Xue, Chrinstina D. Swenson, Kai Chen, Thomas W. Mc Closkey, Lucie-Emily Rows
Publikováno v:
Cancer Research. 80:5593-5593
Personalized immunotherapy for cancer has become an effective treatment choice in certain oncology indications. To successfully develop such therapeutic candidates requires a deep understanding of the biology including the interaction between a varie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3fc43fa351ac0c5a7c26a5bbeb54163
https://doi.org/10.1158/1538-7445.am2020-5593
https://doi.org/10.1158/1538-7445.am2020-5593
Autor:
Kasia E. Cortes, Hong Ji, Anne Charlotte Hegelund, Carl-Magnus Högerkorp, Karen J. Quadrini, Chengsen Xue, Thomas W. Mc Closkey, Susan M. Kennelly
Publikováno v:
Cytometry Part B: Clinical Cytometry. 90:177-190
The C5a/C5a receptor (C5aR) pathway, a key component in the proinflammatory immune response, is an attractive therapeutic target since its dysregulation is implicated in a variety of autoimmune and inflammatory disorders. The objective of the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cae086df78ca16821899ad2f14a709e
https://doi.org/10.1002/cyto.b.21260
https://doi.org/10.1002/cyto.b.21260
Publikováno v:
Cancer Research. 78:5588-5588
Circulating tumor cell (CTC) detection and characterization have recently become an integral part of precision medicine. Several large, multicenter clinical studies confirmed that the prevalence of CTC is a useful predictor of treatment efficacy in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62ed76c01764bc31a8b8b82e14583081
https://doi.org/10.1158/1538-7445.am2018-5588
https://doi.org/10.1158/1538-7445.am2018-5588
Autor:
Maxime Melikian, Chengsen Xue, J.W. Chiao, Luxi Wang, Liying Han, Karim Solangi, Allen Tsao, John T. Fallon, Gildas Bertho, Long G. Wang, Simon Mencher
Publikováno v:
Biochemical pharmacology. 99
A small molecule, Natura-α, a clinical stage investigational new drug for certain inflammatory diseases, has been evaluated for drug interaction with STAT3 and inhibiting systemic lupus erythematosus (SLE). Studies have revealed that it selectively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4dde7f5db341cc2397bef1ff76c09b2
https://pubmed.ncbi.nlm.nih.gov/26612419
https://pubmed.ncbi.nlm.nih.gov/26612419